Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pharmacol Biochem Behav ; 219: 173428, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35868565

RESUMO

Discovery of interventions that delay or minimize age-related diseases is arguably the major goal of aging research. Conversely discovery of interventions based on phenotypic screens have often led to further elucidation of pathophysiological mechanisms. Although most hypotheses to explain lifespan focus on cell-autonomous processes, increasing evidence suggests that in multicellular organisms, neurons, particularly nutrient-sensing neurons, play a determinative role in lifespan and age-related diseases. For example, protective effects of dietary restriction and inactivation of insulin-like signaling increase lifespan and delay age-related diseases dependent on Creb-binding protein in GABA neurons, and Nrf2/Skn1 in just 2 nutrient-sensing neurons in C. elegans. Screens for drugs that increase lifespan also indicate that such drugs are predominantly active through neuronal signaling. Our own screens also indicate that neuroactive drugs also delay pathology in an animal model of Alzheimer's Disease, as well as inhibit cytokine production implicated in driving many age-related diseases. The most likely mechanism by which nutrient-sensing neurons influence lifespan and the onset of age-related diseases is by regulating metabolic architecture, particularly the relative rate of glycolysis vs. alternative metabolic pathways such as ketone and lipid metabolism. These results suggest that neuroactive compounds are a most promising class of drugs to delay or minimize age-related diseases.


Assuntos
Proteínas de Caenorhabditis elegans , Longevidade , Envelhecimento/metabolismo , Animais , Proteína de Ligação a CREB/genética , Proteína de Ligação a CREB/metabolismo , Proteína de Ligação a CREB/farmacologia , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Dieta , Insulina/farmacologia , Longevidade/genética , Neurônios/metabolismo , Nutrientes
2.
Acta Neuropathol ; 144(1): 5-26, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35579705

RESUMO

Traumatic brain injury (TBI) is a leading cause of neurologic impairment and death that remains poorly understood. Rodent models have yet to produce clinical therapies, and the exploration of larger and more diverse models remains relatively scarce. We investigated the potential for brain injury after headbutting in two combative bovid species by assessing neuromorphology and neuropathology through immunohistochemistry and stereological quantification. Postmortem brains of muskoxen (Ovibos moschatus, n = 3) and bighorn sheep (Ovis canadensis, n = 4) were analyzed by high-resolution MRI and processed histologically for evidence of TBI. Exploratory histological protocols investigated potential abnormalities in neurons, microglia, and astrocytes in the prefrontal and parietal cortex. Phosphorylated tau protein, a TBI biomarker found in the cerebrospinal fluid and in neurodegenerative lesions, was used to detect possible cellular consequences of chronic or acute TBI. MRI revealed no abnormal neuropathological changes; however, high amounts of tau-immunoreactive neuritic thread clusters, neurites, and neurons were concentrated in the superficial layers of the neocortex, preferentially at the bottom of the sulci in the muskoxen and occasionally around blood vessels. Tau-immunoreactive lesions were rare in the bighorn sheep. Additionally, microglia and astrocytes showed no grouping around tau-immunoreactive cells in either species. Our preliminary findings indicate that muskoxen and possibly other headbutting bovids suffer from chronic or acute brain trauma and that the males' thicker skulls may protect them to a certain extent.


Assuntos
Lesões Encefálicas Traumáticas , Lesões Encefálicas , Encefalopatia Traumática Crônica , Animais , Encéfalo/patologia , Lesões Encefálicas/patologia , Lesões Encefálicas Traumáticas/diagnóstico por imagem , Lesões Encefálicas Traumáticas/patologia , Bovinos , Encefalopatia Traumática Crônica/patologia , Masculino , Neuropatologia , Proteínas tau/metabolismo
3.
Orthopedics ; 29(11): 1027-9, 2006 11.
Artigo em Inglês | MEDLINE | ID: mdl-17134055

RESUMO

Perioperative autotransfusion is believed to reduce postoperative allogenic transfusion. A retrospective review of 128 patients undergoing total knee arthroplasty with preoperative hemoglobin < 14 g/dL was performed. Group 1 received an intraoperative tourniquet and postoperative autotransfusion. Group 2 received a tourniquet and hemovac drain postoperatively. Group 3 had a tourniquet only during cementing with no drain. Nine (17%) patients in group 1, 9 (19%) patients in group 2, and 4 (15%) patients in group 3 required transfusion. Perioperative autotransfusion does not decrease the need for allogenic transfusion when compared to similar patients at risk for transfusion because of preoperative hemoglobin level < 14 g/dL.


Assuntos
Artroplastia do Joelho , Transfusão de Sangue Autóloga/estatística & dados numéricos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Cuidados Pós-Operatórios , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA